This page lists all known medications that could potentially lead to 'Polyomavirus infections' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

The experimental approach, drawing on decades of research into edible vaccines, uses engineered brewer’s yeast to deliver ...

What is the benefit of the determination of quantitative PCR for polyomavirus in renal transplant recipients? And is there any value in screening kidney donors for polyomavirus? The need for giving ...

A benign virus normally found in the skin can lead to a type of rare, lethal skin cancer. Specifically, infection by the Merkel cell polyomavirus can lead to Merkel cell carcinoma in ...

While uncommon, BK polyomavirus-associated nephropathy is associated with a "substantial" risk of graft loss in kidney transplant recipients. BK polyomavirus-associated nephropathy may increase the ...

What diagnostic procedures should be done on follow-up of a patient who lost renal function after a verified polyomavirus infection in a renal graft, and when should these procedures be performed? Is ...

From July 2001 to April 2004, we used leflunomide as the initial antiviral therapy in 17 patients with biopsy-proven BK nephropathy. All but one of these patients was receiving tacrolimus, prednisone, ...

The BK polyomavirus exhibits tropism for the renal tubular epithelium, where it establishes latent infection. Vigorous immunosuppression of renal allograft recipients can lead to reactivation of the ...

It has recently been shown that Merkel cell carcinoma, a rare and often lethal cutaneous malignancy, frequently harbors a novel clonally integrated polyomavirus aptly named Merkel cell polyomavirus.

BK polyomavirus is a major source of kidney damage and rejection in transplant recipients. But a novel way has been found to decrease BK polyomavirus levels in transplant patients without decreasing ...

Nephropathy associated with the polyomavirus type BK (BKV) nephropathy has emerged as a cause of allograft failure linked to immunosuppressive regimens containing tacrolimus or mycophenolate mofetil.